Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)

Memorial Sloan Kettering Nassau, New York

Fox Chase Cancer Center, Philadelphia

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

Duke University Medical Center, Durham

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Ucla, Los Angeles

University of Washington - Seattle Cancer Care Alliance, Seattle

Yale University, New Haven

Ut Southwestern Medical Center At Dallas, Dallas

Local Institution, Hamilton

Local Institution, Ottawa

Local Institution, Toronto